PT - JOURNAL ARTICLE AU - Charmode, Sundip Hemant AU - Mishra, Abhishek Kumar AU - Mehra, Simmi TI - ‘The Recommended Deltoid Intramuscular Injection Sites in the Adult Population: A Cadaveric study with an Orthopedic Perspective’ AID - 10.1101/2024.06.14.24308929 DP - 2024 Jan 01 TA - medRxiv PG - 2024.06.14.24308929 4099 - http://medrxiv.org/content/early/2024/06/16/2024.06.14.24308929.short 4100 - http://medrxiv.org/content/early/2024/06/16/2024.06.14.24308929.full AB - Background The deltoid is a common site for intramuscular injections, but guidelines for administration lack standardization. Global researchers propose various techniques, and recent study reports indicate a 1.5-15% incidence of nerve palsies due to injections. Our cadaveric study is aimed to standardize the deltoid intramuscular injection sites in the Southeast-Asian population.Methods A cadaveric study of a 2-year duration was conducted in the Department of Anatomy in which twelve upper extremity specimens were dissected by the end of the pilot phase. Anthropometric measurements of deltoid muscle along with the distance of underlying neuro-vascular structures like the Axillary nerve and Posterior Circumflex Humeral Artery were measured from neighboring bony landmarks.Results In adults, in anatomical position, the mean distances of the Axillary nerve, and Posterior Circumflex Humeral Artery from the mid-acromial point are 8.19 ± 0.616 cm; and 8.66 ± 0.968 cm respectively. The deltoid thickness at 3, 5, and 7 cm from mid-acromial point was observed to be 1.079 ± 0.13 cm (0.5 cm to 1.78 cm), 1.599 ± 0.12 cm (1 cm to 2.96 cm), 1.815 ± 1.0 cm (1.2 cm to 2.5 cm) respectively. The acquired qualitative and quantitative data were tabulated, graphically represented, and statistically analyzed.Conclusions The deltoid IMI must be given at or below the level of the midpoint of the deltoid muscle, but never in the upper half. We recommend a site, 4 fingerbreadths / 9cm below the mid-acromion point as the safest site to avoid injury to any underlying neurovascular structures.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was funded by All India Institute of Medical Sciences (AIIMS) RajkotAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Institutional Ethics committee of All India Institute of Medical Sciences (AIIMS) Rajkot gave ethical approval provide PROTOCOL ID- F-IM/15/2023 for this intramural reasrch project.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present work are contained in the manuscript